AA
TDACW

AQR Arbitrage’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

AQR Arbitrage’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$728K Buy
551,505
+3,988
+0.7% +$4K 0.01% 364
2026
Q1 		$65.7K Sell
547,517
-2,475
-0.5% -$567 ﹤0.01% 494
2025
Q4 		$170K Hold
549,992
– – ﹤0.01% 385
2025
Q3 		$159K Sell
549,992
-192,505
-26% -$52.1K ﹤0.01% 358
2025
Q2 		$186K Hold
742,497
– – ﹤0.01% 310
2025
Q1 		$116K Buy
+742,497
New +$131K ﹤0.01% 322

Other funds holding TDACW

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

AQR Arbitrage's TDACW Position: Q2 2026 in Review

AQR Arbitrage increased its Translational Development Acquisition Corp Warrants (TDACW) stake by 0.73% in Q2 2026, buying an estimated $4K and bringing the position to 551,505 shares worth $728K. The position accounts for 0.01% of the portfolio, ranked #364.

AQR Arbitrage first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

  • AQR Arbitrage held 551,505 shares of Translational Development Acquisition Corp Warrants worth $728K as of Q2 2026.
  • AQR Arbitrage bought 3,988 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $4K.
  • Translational Development Acquisition Corp Warrants made up 0.01% of AQR Arbitrage's portfolio in Q2 2026, its #364 holding.
  • AQR Arbitrage first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
  • 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.